Meet the Next Generation of Concentriq: Pathology’s AI Platform for Precision Medicine

Diagnostic labs are being asked to do more than ever: growing workloads, increasingly case complexity, and not enough pathologists to go around. The old playbook, a pathology platform with AI bolted on, can't keep up.

So we built the next generation of Concentriq to be a different kind of platform. The Fifth Generation of Concentriq introduces intelligence that draws from clinical context to support pathologists and lab leaders throughout the decisions that define modern case review. We'll also share new features for life sciences teams, purpose-built to help them drive drug development forward, faster.

Join us for the official first look. We'll demo the platform live, hear directly from customers on the impact, and walk through how Concentriq helps labs deliver high-volume case reviews without sacrificing quality or turnaround time.

In this session, you'll see:

• How the Fifth Generation of Concentriq brings intelligence into everyday case review and lab operations

• What pathologists and lab leaders can accomplish that wasn’t possible before

• Real-world examples of intelligence accelerating case review, lifecycle management, and archive workflows
• A live look at the Fifth Generation of Concentriq in action
• New features for life sciences teams, built to help drive drug development forward

Whether you're a pathologist, lab director, operations leader, or life sciences leader looking to accelerate drug development, this is the session that changes how you think about what your pathology platform can do for you.

Speakers

David West
Chief Executive Officer, Proscia

Coleman Stavish
Chief Technology Officer, Proscia

Dr. Cherub Kim
Director, Medical Affairs and Clinical Informatics Lead, Labcorp

Dr. Daniel Roberts
Medical Director of Digital Pathology, Cleveland Clinic

Dr. Amanda Hemmerich
Global Director of Digital Pathology Innovation, IQVIA Laboratories